CU, P., K, v. S., D, B., M, M., N, B., D, G., . . . C, W. (2017). Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum. Scientific reports, 7(1), 10274. https://doi.org/10.1038/s41598-017-09662-8
Chicago Style (17th ed.) CitationCU, Persson, von Stedingk K, Bexell D, Merselius M, Braekeveldt N, Gisselsson D, Arsenian-Henriksson M, Påhlman S, and Wigerup C. "Neuroblastoma Patient-derived Xenograft Cells Cultured in Stem-cell Promoting Medium Retain Tumorigenic and Metastatic Capacities but Differentiate in Serum." Scientific Reports 7, no. 1 (2017): 10274. https://doi.org/10.1038/s41598-017-09662-8.
MLA (9th ed.) CitationCU, Persson, et al. "Neuroblastoma Patient-derived Xenograft Cells Cultured in Stem-cell Promoting Medium Retain Tumorigenic and Metastatic Capacities but Differentiate in Serum." Scientific Reports, vol. 7, no. 1, 2017, p. 10274, https://doi.org/10.1038/s41598-017-09662-8.